Early Colon Cancer Screening in Your 30s Significantly Reduces Mortality

Doctors are urging people in their 30s to consider the fecal immunochemical test (FIT) as a less invasive, cost-effective screening option for colorectal cancer, which can significantly reduce mortality if detected early. The FIT detects hidden blood in stool, indicating potential cancer or polyps, and is especially recommended for those at higher risk or under 45 who may not qualify for colonoscopies. Regular use of FIT can catch cancer early, but it should be used only if asymptomatic, with follow-up colonoscopies if results are positive.